Form 4: Omada Health CEO Sells Shares
Insider Transaction (Form 4)
Sean P. Duffy, Chief Executive Officer and a Director of Omada Health, Inc., sold 21,570 shares of common stock on August 7, 2026.
Summary
- Option exercise/conversion: acquired 5,545 Common Stock at $8.28 ($45,913) on August 7, 2026; holds 417,406 after (Direct).
- Option exercise/conversion: acquired 3,083 Common Stock at $9.18 ($28,302) on August 7, 2026; holds 420,489 after (Direct).
- Open-market sale: disposed of 4,314 Common Stock at $20.90 ($90,163) on August 7, 2026; holds 416,175 after (Direct).
- Open-market sale: disposed of 4,314 Common Stock at $22.80 ($98,359) on August 7, 2026; holds 411,861 after (Direct).
- Option exercise/conversion: acquired 12,942 Common Stock at $9.18 ($118,808) on August 10, 2026; holds 424,803 after (Direct).
- Open-market sale: disposed of 12,942 Common Stock at $24.81 ($321,059) on August 10, 2026; holds 411,861 after (Direct).
- Option exercise/conversion: disposed of 5,545 Stock Option (Right to Buy) on August 7, 2026; holds 110,532 after (Direct).
- Option exercise/conversion: disposed of 3,083 Stock Option (Right to Buy) on August 7, 2026; holds 530,250 after (Direct).
- Option exercise/conversion: disposed of 12,942 Stock Option (Right to Buy) on August 10, 2026; holds 517,308 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $509,580 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Sean P. Duffy — Director, Officer (Chief Executive Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-07 | Option exercise/conversion | Common Stock | 5,545 | $8 | $45.9K | 417,406 |
| 2026-08-07 | Option exercise/conversion | Common Stock | 3,083 | $9 | $28.3K | 420,489 |
| 2026-08-07 | Open-market sale | Common Stock | 4,314 | $21 | $90.2K | 416,175 |
| 2026-08-07 | Open-market sale | Common Stock | 4,314 | $23 | $98.4K | 411,861 |
| 2026-08-10 | Option exercise/conversion | Common Stock | 12,942 | $9 | $118.8K | 424,803 |
| 2026-08-10 | Open-market sale | Common Stock | 12,942 | $25 | $321.1K | 411,861 |
| 2026-08-07 | Option exercise/conversion | Stock Option (Right to Buy) | 5,545 | — | — | 110,532 |
| 2026-08-07 | Option exercise/conversion | Stock Option (Right to Buy) | 3,083 | — | — | 530,250 |
| 2026-08-10 | Option exercise/conversion | Stock Option (Right to Buy) | 12,942 | — | — | 517,308 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-07 | Option exercise/conversion (5,545 shares) |
| 2026-08-07 | Option exercise/conversion (3,083 shares) |
| 2026-08-07 | Open-market sale (4,314 shares) |
| 2026-08-07 | Open-market sale (4,314 shares) |
| 2026-08-10 | Option exercise/conversion (12,942 shares) |
| 2026-08-10 | Open-market sale (12,942 shares) |
| 2026-08-07 | Option exercise/conversion (5,545 shares) |
| 2026-08-07 | Option exercise/conversion (3,083 shares) |
| 2026-08-10 | Option exercise/conversion (12,942 shares) |
Keywords
insider transaction, Form 4, OMDA, Omada Health, Inc., bearish, Sean P. Duffy
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.